Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer

Yulong Fu(Shenyang Pharmaceutical University), Jian‐An Huang(Soochow University)
Journal of Hematology & Oncology
December 1, 2020
Cited by 162


Related Papers